MYH9 and Thrombocytopenia: MYH9 was initially identified due to abnormalities associated with MYH9 mutations, including conditions like May-Hegglin anomaly (MHA) (Sung et al., 2014), Epstein syndrome (EPS) (Pal et al., 2020), Fechtner syndrome (FTNS) (Li X. et al., 2023), Sebastian syndrome (SBS) (Shin et al., 2011) and other autosomal dominant disorders leading to thrombocytopenia (Althaus and Greinacher, 2009; Furlano et al., 2019).